Literature DB >> 632750

Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.

R M Bartholomew, A F Esser, H J Müller-Eberhard.   

Abstract

Moloney leukemia virus activated both the classical and alternative pathways of human complement. About 500,000 virions were required to detect activation of the classical pathway whereas 5,000 times as many virions were necessary to initiate the alternative pathway, indicating that in this system only the former is of biological significance. Disruption of the virus with Triton X-100 destroyed its ability to initiate the alternative pathway without affecting its ability to activate the classical pathway. After ultracentrifugation of disrupted virus the active component could be recovered in the supernate and was isolated by isoelectric focusing in granulated gels. Sodium dodecyl sulfate-polyacrylamide gel electrophoretic and analysis and cyanogen bromide digestion studies revealed that the activity resided in a methionine-containing protein having a pI of 7.5 and a molecular weight of approximately equal to 15,000 daltons. The purified protein interacts strongly with Clq and efficiently activates Cl. RNase and lipolytic enzymes had no effect on the isolated protein but incubation with trypsin resulted in loss of activity. Enzymatic digestion studies of surface-labeled virus indicate that the active protein is a viral membrane protein. On the basis of these results it is concluded that the complement receptor of Moloney leukemia virus is the surface protein p15E.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632750      PMCID: PMC2184190          DOI: 10.1084/jem.147.3.844

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes.

Authors:  O N Witte; A Tsukamoto-Adey; I L Weissman
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

2.  Common precursor for Rauscher leukemia virus gp69/71, p15(E), and p12(E).

Authors:  W L Karshin; L J Arcement; R B Naso; R B Arlinghaus
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

3.  Protein iodination with solid state lactoperoxidase.

Authors:  G S David; R A Reisfeld
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

4.  A proposed nomenclature for the virion proteins of oncogenic RNA viruses.

Authors:  J T August; D P Bolognesi; E Fleissner; R V Gilden; R C Nowinski
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

5.  Isoelectric focusing in Pevikon slabs.

Authors:  W I Otavsky; T Bell; C Saravis; J W Drysdale
Journal:  Anal Biochem       Date:  1977-03       Impact factor: 3.365

6.  Inactivation of lysis of oncornaviruses by human serum.

Authors:  R M Welsh; F C Jensen; N R Cooper; M B Oldstone
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

7.  Lysis of oncornaviruses by human serum.

Authors:  F C Jensen; R M Welsh; N R Cooper; M B Oldstone
Journal:  Bibl Haematol       Date:  1975-10

8.  The first complement component: evidence for an equilibrium between C1s free in serum and C1s bound in the C1 complex.

Authors:  R M Bartholomew; A F Esser
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

9.  The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution.

Authors:  W P Kolb; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

10.  Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.

Authors:  N R Cooper; F C Jensen; R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  35 in total

1.  Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.

Authors:  J A van Strijp; K P van Kessel; L A Miltenburg; A C Fluit; J Verhoef
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Retrovirus-induced feline pure red cell aplasia. Hematopoietic progenitors are infected with feline leukemia virus and erythroid burst-forming cells are uniquely sensitive to heterologous complement.

Authors:  J L Abkowitz; R D Holly; C K Grant
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 3.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.

Authors:  Y Takeuchi; F L Cosset; P J Lachmann; H Okada; R A Weiss; M K Collins
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 5.  The complement system: its importance in the host response to viral infection.

Authors:  R L Hirsch
Journal:  Microbiol Rev       Date:  1982-03

6.  Envelope polypeptides of Friend leukemia virus: purification and structural analysis.

Authors:  J Schneider; H Falk; G Hunsmann
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

7.  Disassembly of viral membranes by complement independent of channel formation.

Authors:  A F Esser; R M Bartholomew; F C Jensen; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.

Authors:  J Schmitz; J P Zimmer; B Kluxen; S Aries; M Bögel; I Gigli; H Schmitz
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Neutralizing antibody response of rabbits and goats to caprine arthritis-encephalitis virus.

Authors:  P Klevjer-Anderson; T C McGuire
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera.

Authors:  D G Miller; A D Miller
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.